Low-dose fluvoxamine modulates endocytic trafficking of SARS-CoV-2 spike protein: a potential mechanism for anti-COVID-19 protection by antidepressants
This study shows that low-dose fluvoxamine increases endocytic trafficking of SARS-CoV-2 spike protein and ACE2, potentially explaining its protective effect against COVID-19.
bioRxiv · Jun 15, 2021Cell Biology